The Drug Enforcement Administration is proposing to list PMK glycidate, PMK glycidic acid, precursors used in the manufacture of methylenedioxymethamphetamine (MDMA) (also known as ecstasy), as well as alpha-phenylacetoacetamide (APAA), a precursor used to make amphetamine and methamphetamine, as schedule II substances under the Controlled Substances Act, it said in a notice released Dec. 18. “If finalized, this action would subject handlers (manufacturers, distributors, importers, and exporters) of PMK glycidate, PMK glycidic acid, and APAA to the chemical regulatory provisions of the CSA and its implementing regulations,” DEA said. Comments are due Feb. 19, 2021.
The Federal Trade Commission seeks comments on “the overall costs, benefits, necessity, and regulatory and economic impact” of its regulations on power output claims for amplifiers used in home entertainment products, it said in a notice released Dec. 17. Established in 1974, the rules set uniform measurements and disclosures for home entertainment amplifiers. The request for comment comes as part of “a systematic review of all current FTC rules and guides,” the FTC said. Comments are due Feb. 16, 2021.
The Drug Enforcement Administration is proposing to remove samidorphan from schedule II of the Controlled Substances Act, it said in a proposed rule released Dec. 9. DEA said the drug has no abuse potential. If the removal is finalized, DEA would eliminate “regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle” samidorphan, it said. Comments are due Jan. 11, 2021.
The Drug Enforcement Administration plans to temporarily add the synthetic opioid brorphine to Schedule I of the Controlled Substances Act, it said in a notice released Dec. 2. Once the temporary scheduling order is published, it will be in effect for up to three years, the DEA said.
The Drug Enforcement Administration is setting 2021 quotas for the manufacture and importation of controlled substances in schedules I and II of the Controlled Substances Act, it said in a Nov. 30 notice. Substances not listed in the table included in DEA's notice will have a quota of zero. DEA is also setting quotas for the Schedule I chemicals ephedrine, phenylpropanolamine and pseudoephedrine.
The Drug Enforcement Administration is finalizing adjusted 2020 quotas for the manufacture and import of controlled substances in schedules I and II of the Controlled Substances Act, it said in a notice released Nov. 30. Substances not listed in the table included in DEA's final rule will have a quota of zero. DEA is also setting quotas for the Schedule I chemicals ephedrine, phenylpropanolamine and pseudoephedrine.
The Drug Enforcement Administration permanently placed the synthetic opioids cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl and valeryl fentanyl into Schedule I of the Controlled Substances Act, in a final rule published Nov. 25. The substances had been temporarily listed in Schedule I since 2018. The final rule takes effect Nov. 25.
The International Trade Commission seeks comments on recommended changes to the tariff schedule that would take effect on Jan. 1, 2022. Required to implement the 2022 version of the World Customs Organization’s Harmonized System, which is updated every five years and forms the six-digit backbone of the U.S. tariff schedule, the proposed changes would be the most extensive since the last time the HS was updated in 2017. Affected products include, among others, 3D printers, drones, smartphones, electric vehicles, e-waste, antiquities, olive oil and test kits for mosquito-borne diseases. Comments are due to the ITC by 5:15 p.m. EST on Dec. 14, the commission said in a Nov. 20 news release. The ITC will submit its final recommendations to the White House in March 2021.
The International Federation of Freight Forwarders Associations issued a “toolkit” for industry to better understand and apply the Federal Maritime Commission’s May rule on detention and demurrage fees (see 2004290037). The toolkit, released last week, summarizes the rule, details its applicability and scope, and analyzes industry objections. The FMC recently announced an investigation into whether ocean carriers are violating regulations on detention and demurrage charges (see 2011200024), after industry said the rule is being ignored (see 2011170041).
A new State Department paper warning of China and its global trade ambitions “only serves to lay bare the entrenched Cold War mindset and ideological prejudice of some people on the U.S. side and their fear, anxiety and unhealthy mentality towards a growing China,” a Chinese Foreign Affairs Ministry spokesperson said, according to a press conference transcript. “Their vile attempts to bring back the Cold War will be mercilessly rejected by the Chinese people and all peace-lovers around the world,” he said. The Chinese Communist Party “aims not merely at preeminence within the established world order,” but to “fundamentally revise world order,” with China at the center and serving “Beijing’s authoritarian goals and hegemonic ambitions,” according to the Policy Planning staff paper, “The Elements of the China Challenge.” It proposes a “tasks” list to “refashion” U.S. policy by educating Americans “about the scope and implications” of the alleged threat and training a “new generation of public servants” fluent in Chinese. The U.S. also “must promote American interests by looking for opportunities to cooperate with Beijing subject to norms of fairness and reciprocity,” it says. The State Department didn’t respond to questions Nov. 19.